Abstract:Phototheranostics involving both fluorescence imaging and photodynamic therapy has been recognized to be potentially powerful for cancer treatment by virtue of various intrinsic advantages. However, the state-of-the-art materials in this area are still far from ideal toward practical applications, ascribed to their respective and collective drawbacks, such as inefficient imaging quality, inferior reactive oxygen species (ROS) production, the lack of subcellular-targeting capability, and dissatisfactory delivery. In this paper, these shortcomings are successfully addressed through the integration of finely engineered photosensitizers with aggregation-induced emission (AIE) features and well tailored nanocarrier systems. The yielded AIE NPs simultaneously exhibit broad absorption in the visible-light region, bright near-infrared fluorescence emission, high ROS generation, as well as tumor lysosomal acidity-activated and nucleus-targeted delivery functions, making them promising for precise and efficient phototheranostics. Both in vitro and in vivo evaluations show that the presented nanotheranostic systems bearing good photostability and appreciable biosecurity perform well in fluorescence imaging-guided photodynamic cancer therapy. This study thus not only extends the application scopes of AIE nanomaterials but also offers useful insights into constructing advanced cancer phototheranostics.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.1c03700?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.1c03700</a>.Detailed synthetic procedures, structural characterizations, optical data, calculation results, ROS discrimination, storage stability, photostability test, ex vivo fluorescence images, survival curves, and routine blood and serum biochemical indexes (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.1c03700/suppl_file/nn1c03700_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Add the Finishing Touch: Molecular Engineering of Conjugated Small Molecule for High‐Performance AIE Luminogen in Multimodal Phototheranostics

Aggregation‐induced Emission Luminogens for in Vivo Molecular Imaging and Theranostics in Cancer

Tuning Long-Term Mitochondrial Imaging and Photodynamic Therapy Capabilities Through Rational Design of Aggregation-Induced Emission Luminogens

Zwitterionic AIEgens: Rational Molecular Design for NIR‐II Fluorescence Imaging‐Guided Synergistic Phototherapy

Endowing AIE with Extraordinary Potential: A New Au(I)‐Containing AIEgen for Bimodal Bioimaging‐Guided Multimodal Synergistic Cancer Therapy

Molecular Engineering of High-Performance Aggregation-Induced Emission Photosensitizers to Boost Cancer Theranostics Mediated by Acid-Triggered Nucleus-Targeted Nanovectors

Regulating Aggregation‐Induced Emission Luminogen for Multimodal Imaging‐Navigated Synergistic Therapy Involving Anti‐Angiogenesis

Highly Efficient Singlet Oxygen Generation of AIE Luminogens Enable Mitochondria-Targeted Photodynamic Therapy

Side‐Chain Engineering of Aggregation‐Induced Emission Molecules for Boosting Cancer Phototheranostics

One-for-all phototheranostics: Single component AIE dots as multi-modality theranostic agent for fluorescence-photoacoustic imaging-guided synergistic cancer therapy

Near‐Infrared II AIE Luminogens with Mitochondria‐Targeting Characteristics for Combinational Phototherapies of Breast Tumors Through Synergistic Cell Apoptosis and Pyroptosis

Boost Highly Efficient Singlet Oxygen Generation and Accelerate Cancer Cell Apoptosis for Photodynamic Therapy by Logically Designed Mitochondria Targeted Near-Infrared AIEgens

Molecular Engineering for Boosting AIE-active Free Radical Photogenerator and Its High-performance in Hypoxia via Photodynamic Therapy

Theoretical Insights into Rational Design of Small Organic Phototheranostic Agents for Promoting Image-Guided Cancer Surgery

Molecular Engineering to Boost AIE‐Active Free Radical Photogenerators and Enable High‐Performance Photodynamic Therapy under Hypoxia

Utilizing a Pyrazine-Containing Aggregation-Induced Emission Luminogen As an Efficient Photosensitizer for Imaging-Guided Two-Photon Photodynamic Therapy.

Bright Near-Infrared Aggregation-Induced Emission Luminogens with Strong Two-Photon Absorption, Excellent Organelle Specificity, and Efficient Photodynamic Therapy Potential

Molecular Engineering of NIR-II/IIb Emitting AIEgen for Multimodal Imaging-Guided Photo-Immunotherapy.

Chemiluminescent Afterglow Material for Enhanced Tumor Diagnosis and Photodynamic Therapy

Mitochondria‐Targeting Phototheranostics by Aggregation‐Induced NIR‐II Emission Luminogens: Modulating Intramolecular Motion by Electron Acceptor Engineering for Multi‐Modal Synergistic Therapy

Simultaneously Boosting the Conjugation, Brightness and Solubility of Organic Fluorophores by Using AIEgens.